Codiak BioSciences | Exosome Therapy

  Codiak Biosciences is exploring methods of using exosomes as cell-free therapeutics, and its success in this area is promising. According to the company, Codiak can “precisely control the signals either on the surface of or within the exosome, and deliver a precise signal(s) to promote a therapeutic effect.”

Founded in 2015, Codiak was formed when the MD Anderson Cancer Center joined with two venture capital firms and co-founder Dr. Eric Lander to launch the company, with $80 million in series A and B financing.

  Kimera Labs | Exosome Stem Cells Research

  Kimera Labs is a biotechnology company with an FDA registered tissue facility that develops “umbilical cord and organ based exosome products for research and therapeutic purposes.” In addition to offering cosmeceutical products, such as its XOGLO™ skin therapy, it is exploring exosome methods and therapy protocols for use in treating burns, orthopedics, and inflammatory diseases.

The company has an incredible burn patient case study that can be seen here.

  ExCoBio, Inc. | Anti-Aging Exosome Treatment

  A “cosmeceutical” is a cosmetic product that has medicinal properties, most commonly, anti-aging properties. ExCoBio, Inc. is a market leader in the area of exosome-based cosmeceuticals, but other players are beginning to appear, particularly within East Asia.

ExoCoBio is a venture-backed startup that develops exosome-based cosmeceuticals and biopharmaceuticals for skin and tissue regeneration that is headquartered in South Korea.